NASDAQ:SYRA - Nasdaq - US87168W2035 - Common Stock - Currency: USD
SYRA HEALTH CORP - CLASS A
NASDAQ:SYRA (2/4/2025, 8:10:04 PM)
Premarket: 0.451 0 (0%)0.451
0 (-0.55%)
The current stock price of SYRA is 0.451 USD. In the past month the price increased by 0.27%. In the past year, price decreased by -84.55%.
Syra Health sees a surge in stock prices after securing a significant contract with Washington D.C. for student healthcare services. Syra Health will deploy nurses and assistants to support student well-being.
/PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing...
/PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing...
/PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing...
/PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), ("Syra Health" or the "Company") a healthcare technology company driving better health through impactful,...
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 10.66 | 81.07B | ||
CVS | CVS HEALTH CORP | 8.87 | 70.91B | ||
LH | LABCORP HOLDINGS INC | 17.11 | 20.63B | ||
DGX | QUEST DIAGNOSTICS INC | 18.11 | 18.23B | ||
DVA | DAVITA INC | 19.97 | 14.54B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 176.57 | 14.45B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 14.8 | 14.42B | ||
HIMS | HIMS & HERS HEALTH INC | 95.11 | 9.14B | ||
CHE | CHEMED CORP | 24.34 | 8.35B | ||
CRVL | CORVEL CORP | 26.46 | 6.40B | ||
GH | GUARDANT HEALTH INC | N/A | 5.83B | ||
OPCH | OPTION CARE HEALTH INC | 25.97 | 5.26B |
Syra Health Corp. operates as a medical technology company. The company is headquartered in Carmel, Indiana and currently employs 78 full-time employees. The company went IPO on 2023-09-29. The firm provides comprehensive end-to-end solutions in behavioral and mental health, population health, digital health, health education and healthcare workforce. The Company’s health education service line offers services, including medical communications, patient education, and healthcare training. Its population health management services include analytics as a service, epidemiology and health equity analytics solutions. The Company’s digital health solutions include digital transformation, cloud and security, artificial intelligence, patient engagement, and health applications. Its Syrenity is a comprehensive mental health application that provides preventative care and interventions for behavioral and mental health. The company provides medical education solutions to pharmaceutical and medical device manufacturers, biotechnology companies, payers, large employers, academic institutions, and government agencies.
SYRA HEALTH CORP - CLASS A
1119 Keystone Way N., #201
Carmel INDIANA US
Employees: 120
Company Website: https://www.syrahealth.com/
Phone: 14633458950
The current stock price of SYRA is 0.451 USD.
The exchange symbol of SYRA HEALTH CORP - CLASS A is SYRA and it is listed on the Nasdaq exchange.
SYRA stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for SYRA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of SYRA.
SYRA does not pay a dividend.
SYRA does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.65).
The outstanding short interest for SYRA is 12.72% of its float.
ChartMill assigns a technical rating of 3 / 10 to SYRA. When comparing the yearly performance of all stocks, SYRA is a bad performer in the overall market: 93% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to SYRA. SYRA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months SYRA reported a non-GAAP Earnings per Share(EPS) of -0.65. The EPS increased by 7% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -96.05% | ||
ROE | -127.61% | ||
Debt/Equity | 0.07 |
For the next year, analysts expect an EPS growth of -6% and a revenue growth 33.64% for SYRA